Nastech, Pohl-Boskamp morphine deal

NSTK granted G. Pohl-Boskamp (Hohenlockstedt, Germany) exclusive rights in Europe to develop and market NSTK's intranasal morphine to treat moderate-to-severe pain. NSTK will receive an upfront licens...